Hospital das Clínicas da Universidade Federal de Goiás - UFG
Hospital das Clínicas da Universidade Federal de Goiás - UFG
Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Rodrigo Sebba Aires
Open studies
Cardiovascular disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Rare diseases
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease - LIBRA - SanofiSee more
Heart failure
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Inflammation
A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation - HERMES - Novo Nordisk A/SSee more
Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Anemia
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia - LUMINA 3 - SanofiSee more
Prolactinoma
Safety and Potency of a High Cabergoline Dosage in Microprolactinomas - SPARAGMOS - University of Sao Paulo General HospitalSee more
Crohn's disease
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease - AMAY - Eli Lilly and CompanySee more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Cholangitis
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis - VANTAGE - Mirum Pharmaceuticals, Inc.See more
Hemolytic Disease
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) - AZALEA - Janssen Research & Development, LLCSee more
